Copy number signatures and mutational processes in ovarian carcinoma

Journal: Nature Genetics

Published: 2018-08-13

DOI: 10.1038/s41588-018-0179-8

Affiliations: 25

Authors: 39

Go to article
Institutions FC
Institute of Cancer Sciences (ICS), University of Glasgow, United Kingdom (UK) 0.20
Cancer Research UK Cambridge Institute (CRUK-CI), University of Cambridge, United Kingdom (UK) 0.19
Queen Elizabeth University Hospital Glasgow, United Kingdom (UK) 0.08
Addenbrooke's Hospital, United Kingdom (UK) 0.06
VU University Medical Center (VUmc), Netherlands 0.05
Glasgow Cancer Research UK Clinical Trials Unit, University of Glasgow, United Kingdom (UK) 0.05
Ovarian Cancer Action Research Centre (OCARC), United Kingdom (UK) 0.05
Beatson West Of Scotland Cancer Centre (BWoSCC), United Kingdom (UK) 0.03
Mount Vernon Cancer Centre, United Kingdom (UK) 0.03
MRC Institute of Genetics and Molecular Medicine (IGMM), The University of Edinburgh, United Kingdom (UK) 0.03
The Christie NHS Foundation Trust, United Kingdom (UK) 0.03
Leeds Teaching Hospitals NHS Trust (LTHT), United Kingdom (UK) 0.03
Birmingham City Hospital, SWBH, United Kingdom (UK) 0.03
University Hospitals Bristol NHS Foundation Trust (UHBristol), United Kingdom (UK) 0.03
Guy's Hospital, Guy's and St Thomas' NHS Foundation Trust, United Kingdom (UK) 0.03
Barts Health NHS Trust, United Kingdom (UK) 0.03
Centre for Eye Research Australia (CERA), Australia 0.01
University College Hospital (UCH), United Kingdom (UK) 0.01
Barts Cancer Institute (BCI), QMUL, United Kingdom (UK) 0.01
AstraZeneca IMED Biotech Unit Cambridge, United Kingdom (UK) 0.01
Manchester University NHS Foundation Trust (MFT), United Kingdom (UK) 0.01
Health Innovation Manchester, United Kingdom (UK) 0.01
Institute of Cancer Sciences, UoM, United Kingdom (UK) 0.01
Department of Oncology, University of Cambridge, United Kingdom (UK) 0.01

Return